An additional report suggested that pharmacological systemic P53 activation can even ameliorate chemically induced diabetes [40], while ablation of one key inhibitor of P53 (MDM2) resulted in reduced insulin secretion without any effect on beta cell mass [68]. The gene discussed is INS; the disease is diabetes mellitus.